Close this search box.

We are creating some awesome events for you. Kindly bear with us.

HTCM first hospital in Southeast Asia to use UCPFlex tech

Image Credits: UKM, Press Release

Chancellor Tuanku Mukhriz Hospital (HTCM), National University of Malaysia (UKM) is the first hospital in Southeast Asia to use Ultrasound Cyclo Plasty (UCPFlex) technology in treating glaucoma patients.

UCPFlex is a technology that uses high-intensity focused Ultrasound to control and destroy the body of the eye.

According to HTCM Ophthalmologist, technology has fewer side-effects compared to the previously used Cyclodiode laser surgeries and treatments.

UCPFlex also has a faster cure rate than other treatments. This technology gives patients the option to choose the treatment they want.

As far as March 2020, the team has tried this treatment for eight patients at HTCM, and all have shown good results, the professor stated.

The science behind Ultrasound Cyclo-Plasty technology

Outside of ophthalmology ultrasound has been used to treat various diseases such as tendonitis, kidney stones, and uterine fibroids.

Within ophthalmology, ultrasound has been used for decades to image the structures of the eye as well as to remove cataracts. Using ultrasound to treat glaucoma, however, is relatively new.

Ultrasound devices all share one characteristic: they create high-frequency sound waves that are beyond the range detectable by the human ear.

Diagnostic ultrasounds also measure the waves that have been reflected off tissues (this is how the image is created). Therapeutic ultrasound devices tend to create higher energy waves with the goal of altering or destroying tissue.

Developed in France by EyeTechCare, the EyeOP1® uses high intensity focused ultrasound (HIFU) to lower IOP. It does this by focusing this energy on the ciliary body which produces the aqueous fluid within the eye.

The ultrasound energy changes the structure of the ciliary body by essentially destroying a portion of it. Because less tissue is left to produce aqueous fluid, the intraocular pressure (IOP) is reduced.

As with many new glaucoma procedures, the first to try it are often those who have failed accepted methods of IOP control. However, what most patients with glaucoma who are initially facing surgery want to know is, “Will newer, less invasive surgeries benefit me?”

In November 2015, the results were published of a small study attempting to answer this question. Thirty patients with glaucoma but without prior incisional surgery underwent EyeOP1® UCP. By one year out the average IOP was reduced by 30% compared to before UCP.

There was, however, no clinically significant reduction in the number of medications needed to control the IOP.

It should be noted that this study was funded by EyeTechCare, the maker of the EyeOP1®. Given that EyeTechCare stands to profit from positive clinical results, the findings of this study need to be replicated by an independent group of researchers.

EyeOP1® UCP appears to be another step-wise improvement of the broader glaucoma treatment category of cyclo-destructive procedures. Importantly, the risks of EyeOP1® UCP are notably less worrisome compared to earlier methods of ciliary body alteration.

More recently, the UCPFlex is a technology was introduced into Southeast Asia by a leading eye care technology provider, Excimed Sdn. Bhd.

They chose HTCM for a variety of reasons, including SMEs strongly encouraging the research and use of new technologies.

The technology is expected to be introduced to other hospitals after the successful treatment at HTCM.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.